AKT1 and breast cancer: Our findings confirms a previous study by Peng et al. in breast cancer cell-lines, transfected with myristoylated AKT (Myr-AKT) isoforms via retroviral delivery system, where AKT isoforms uniformly decreased the frequency of CD44 subpopulations [64].